Skip to content

Precise 3D Surview

Precise 3D Surview Clinical Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07267533
Acronym
3D Surview
Enrollment
274
Registered
2025-12-05
Start date
2026-01-31
Completion date
2026-10-01
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Computed Tomography

Brief summary

The purpose of the study is to assess the performance of Precise 3D Surview on CT 5300 and Incisive CT Scanners as compared with manual annotation by experienced CT technologists. * To evaluate the acceptance rate of the Auto 3D Planning Box compared with manual annotation by experienced CT technologists. * To evaluate the acceptance rate of the Auto Suggestion for Locator compared with manual annotation by experienced CT technologists. * To evaluate the acceptance rate of the Auto Planning for Truncated Anatomies (lung and liver) compared with manual annotation by experienced CT technologists. * To evaluate the acceptance rate of Auto Planning and Symmetry Correction for Tilted Head compared with manual annotation by experienced CT technologists.

Interventions

None listed

Sponsors

Philips Healthcare (Suzhou) Co., Ltd.
CollaboratorINDUSTRY
Philips Clinical & Medical Affairs Global
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects scanned by CT 5300 (K232491) and Incisive CT (K212441) according to the department standard of care clinical protocols. * Subjects age is over eighteen (18) years1. * Patients scanned in supine orientation. * Non-contrast CT scan * CT scan with standard resolution

Exclusion criteria

* Subjects age is under or equal 18 years old * Patients are not scanned in supine orientation. * Contrast-enhanced CT scans. * CT scans with high resolution * Scans that are not completed due to technical difficulties

Design outcomes

Primary

MeasureTime frame
Acceptance rate of the 3D SurviewReading session at 4 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026